intraperitoneal microdialysis after server infektion i the peritoneal cavity

Phase 1

• Conditions: server peritonitis; Therapeutic area: Body processes [G] - Digestive System and Oral Physiological Phenomena [G10]

• Registration Number: EUCTR2012-004398-22-DK
• Lead Sponsor: Afd. A, OUH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-04-10
• Last Update Posted: 6 October 2020

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

Suspecting peritonitis: perforated ulcer, perforated, diverticulitis of colon, perforated appendicitis, anastomitix leakage
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 25
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 25

Exclusion Criteria

Local abces
eGFR<30

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Main Objective: Comparing the intraperitoneal concentrations og antibiotics ( meronem, cefuroxim, tazocin, metronidazol og diflucan) with the patients clinic after operation for server peritonitis;Secondary Objective: Mesuring intraperitoneal concentration of metabolits ( glucose, glycerol, lactat, pyruvat, glutamat ) and cytocins.;Primary end point(s): -;Timepoint(s) of evaluation of this end point: 2018

Secondary Outcome Measures

Name	Time	Method
Secondary end point(s): -;Timepoint(s) of evaluation of this end point: 2018